GlassScriptPhysician profile
Tara R Simon
NPI 1972915338
$10,852.36
in general payments reported to CMS, 2019-2025
61 companies · $2,176 in 2025
The $2,176 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,175 · 2022: $2,013 · 2023: $2,530 · 2024: $1,957 · 2025: $2,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,597 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,596.96 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,362.87 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Abbvie INC. | $984.81 | 2021-2024 | |
| Harmony Biosciences LLC | $960.93 | 2021-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $822.94 | 2021-2025 | Ofev, Jardiance, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $686.68 | 2021-2025 | Glassia, Trintellix |
| Amgen INC. | $633.36 | 2021-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $617.94 | 2021-2025 | Tezspire, Fasenra, Breztri |
| Novo Nordisk INC | $487.27 | 2021-2025 | Wegovy, Ozempic |
| Jazz Pharmaceuticals INC. | $437.22 | 2021-2025 | |
| Axsome Therapeutics, INC. | $397.95 | 2022-2025 | Sunosi |
| Pfizer INC. | $313.18 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $269.98 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $254.74 | 2021-2025 | Winrevair, Gardasil, Capvaxive |
| Regeneron Healthcare Solutions, INC. | $223.37 | 2023-2025 | Dupixent |
| Verona Pharma, INC. | $208.70 | 2025 | Ohtuvayre |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.